Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data.
Elmunzer, B Joseph
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. [electronic resource] - The American journal of gastroenterology Mar 2013 - 410-5 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1572-0241
10.1038/ajg.2012.442 doi
Administration, Rectal
Adult
Aged
Cholangiopancreatography, Endoscopic Retrograde--adverse effects
Cost-Benefit Analysis
Female
Humans
Indomethacin--administration & dosage
Male
Middle Aged
Pancreatitis--economics
Prospective Studies
Retrospective Studies
Risk Factors
Stents--economics
Treatment Outcome
Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. [electronic resource] - The American journal of gastroenterology Mar 2013 - 410-5 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1572-0241
10.1038/ajg.2012.442 doi
Administration, Rectal
Adult
Aged
Cholangiopancreatography, Endoscopic Retrograde--adverse effects
Cost-Benefit Analysis
Female
Humans
Indomethacin--administration & dosage
Male
Middle Aged
Pancreatitis--economics
Prospective Studies
Retrospective Studies
Risk Factors
Stents--economics
Treatment Outcome